Resapp Health Ltd
ASX:RAP

Watchlist Manager
Resapp Health Ltd Logo
Resapp Health Ltd
ASX:RAP
Watchlist
Price: 0.205 AUD
Market Cap: AU$176.2m

Net Margin

-282.1%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-282.1%
=
Net Income
AU$-7.1m
/
Revenue
AU$2.5m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-282.1%
=
Net Income
AU$-7.1m
/
Revenue
AU$2.5m

Peer Comparison

Country Company Market Cap Net
Margin
AU
Resapp Health Ltd
ASX:RAP
176.2m AUD
Loading...
US
Veeva Systems Inc
NYSE:VEEV
36.5B USD
Loading...
US
Cerner Corp
LSE:0R00
31.3B USD
Loading...
AU
Pro Medicus Ltd
ASX:PME
18.9B AUD
Loading...
JP
M3 Inc
TSE:2413
1.4T JPY
Loading...
US
Doximity Inc
NYSE:DOCS
7.6B USD
Loading...
US
Waystar Holding Corp
NASDAQ:WAY
5.2B USD
Loading...
SE
Sectra AB
STO:SECT B
43.2B SEK
Loading...
CN
Winning Health Technology Group Co Ltd
SZSE:300253
26.7B CNY
Loading...
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
283.3B INR
Loading...
US
Heartflow Inc
NASDAQ:HTFL
2.7B USD
Loading...

Market Distribution

In line with most companies in Australia
Percentile
35th
Based on 4 004 companies
35th percentile
-282.1%
Low
-16 177 900% — -544.7%
Typical Range
-544.7% — 3.1%
High
3.1% — 3 174 540%
Distribution Statistics
Australia
Min -16 177 900%
30th Percentile -544.7%
Median -27.7%
70th Percentile 3.1%
Max 3 174 540%

Resapp Health Ltd
Glance View

Market Cap
176.2m AUD
Industry
Health Care

ResApp Health Ltd. engages in the research and commercial development of ResApp technology for the purpose of providing health care solutions for respiratory disease. The company is headquartered in Brisbane, Queensland. The company went IPO on 2005-01-12. The Company’s digital healthcare solutions assists doctors and patients to diagnose and manage respiratory disease. The firm has developed a platform for diagnosing respiratory disease using the sound of a patient’s cough. The platform is based on sound alone and does not require physical contact with the patient. With smartphones integrating microphones, the platform can be delivered without the need for additional hardware. The firm has developed smartphone-based machine learning algorithms, which can identify exacerbations in patients with asthma or COPD. The company also has ongoing clinical programs investigating the use of these techniques to measure exacerbation severity and lung function. The firm has developed an obstructive sleep aponia screening test that uses overnight breathing and snoring sounds recorded on a smartphone placed on the bedside table.

RAP Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-282.1%
=
Net Income
AU$-7.1m
/
Revenue
AU$2.5m
How has Net Margin changed over time?

Over the last 3 years, Resapp Health Ltd’s Net Margin has increased from -5 780.6% to -282.1%. During this period, it reached a low of -16 541.4% on Jun 30, 2020 and a high of -282.1% on Jun 30, 2022.

Back to Top